The Diagnostic Imaging CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.
November 20th 2024
While a large retrospective study found that interstitial lung abnormalities (ILAs) were evident on 1.7 percent of computed tomography (CT) scans, researchers found that 43.9 percent of ILAs, including fibrotic ILAs, were not reported.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
New Clinical Imaging Tech Promises Improved Image Quality
March 22nd 2012Researchers want to make photoacoustic tomography, which pairs light and sound, available to providers. Clinical trials are already under way to visualize sentinel lymph nodes for breast cancer staging – just one of several potential applications of this technology.
Follow-on Brain CT Key for those on Blood Thinners
January 20th 2012A follow-on CT scan can help lower risks of brain hemorrhage for patients with minor head injuries who are taking the anticoagulant warfarin, according to a study published online this week in the Annals of Emergency Medicine.
Optical Coherence Tomography Gaining Ground as Major Modality
December 28th 2011Once limited to research and use by eye specialists, optical coherence tomography (OCT) is emerging as a major imaging modality. OCT is more sensitive than ultrasound, experts said, and now researchers and clinicians are now finding ways to use OCT to guide esophageal and cervical biopsies.
Decision Support Cuts CT Pulmonary Angiography Orders from ED
December 22nd 2011The use of clinical decision support in the emergency room cuts the need for CT pulmonary angiography for acute pulmonary embolism by 20 percent and boosts yield 69 percent, according to a study published online on Dec. 20 in the journal Radiology.
Considering WellPoint's Decision to Cover CT Lung Screening
December 21st 2011WellPoint’s decision earlier this month to cover CT scans for heavy smokers may encourage other insurers to follow suit, paving the way for imaging sites to set up screening programs. But, for now, payers and practices alike are waiting to see what happens next.
FDA Approves Handheld Intracranial Hematoma Detector
December 19th 2011The U.S. Food and Drug Administration has approved the first handheld device to detect intracranial hematomas - bleeding in the skull - which the agency says can help determine if patients with critical injuries need an immediate CT scan.
KLAS: Docs Perceive Siemens, GE as CT Low-Dose Leaders
December 14th 2011While providers are paying special mind in lowering radiation dose through prep work and process improvements, they do have their opinions on which CT vendors are the low dose leaders, according to a new report from KLAS, CT 2011: Focused on Dose.
CT Finds Heart Disease Despite Zero Coronary Artery Calcification
November 14th 2011Coronary artery calcification (CAC) scores of zero don’t give patients a pass from obstructive coronary artery disease, according to a study using coronary computed tomography angiography (CCTA) on patients with symptoms of coronary artery disease.
Philips’ CT Focus at RSNA 2011 on iDose4 and Ingenuity Suite
November 11th 2011Scott Smith, director of project management, CT, Philips Healthcare, describes low-dose CT as nearly a given in the marketplace now. What’s more important is maintaining the speed and quality of the image while using iterative reconstruction to keep the dose low.